Human Patient-Derived Colorectal Cancer Organoid – Sigmoid Colon APC, TP53, SMAD4 is a 3D tumor model cultured from sigmoid colon tissue of a colorectal cancer patient. This organoid harbors key oncogenic mutations in APC, TP53, and SMAD4, representative of advanced colorectal cancer with dysregulated Wnt signaling, impaired DNA damage response, and TGF-β pathway disruption. It preserves the histological structure, genetic integrity, and tumor heterogeneity of the original tissue. The organoid supports sustained in vitro growth, making it ideal for research in site-specific colorectal cancer progression and therapy response.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Patient-Derived Colorectal Cancer Organoid – Sigmoid Colon APC, TP53, SMAD4 model is highly relevant for investigating targeted therapies against Wnt and TGF-β pathways, understanding the synergy of multiple driver mutations, and validating new treatment combinations. It enables functional assays to evaluate drug resistance, biomarker identification, and tumor evolution. As a representative model of mutation-enriched sigmoid colon cancer, it supports personalized therapy development and translational research into molecularly stratified treatment strategies.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.